Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-5067
Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas Health Sciences CenterM.S., Clinical Research, 2004 - 2008
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
- Temple University HospitalResidency, Internal Medicine, 1999 - 2002
- Boston University School of MedicineClass of 1999
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2002 - 2027
- AZ State Medical License 2022 - 2026
- GA State Medical License 2022 - 2026
- TN State Medical License 2022 - 2026
- AL State Medical License 2022 - 2025
- LA State Medical License 2022 - 2025
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia Start of enrollment: 2006 Aug 02
- Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia Start of enrollment: 2010 Oct 06
- Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma Start of enrollment: 2015 Feb 26
- Join now to see all
Publications & Presentations
PubMed
- Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy.Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, Aaron Seo, Lewis F Nasr
Clinical Lymphoma, Myeloma & Leukemia. 2025-04-01 - Zanubrutinib in Bing Neel syndrome: efficacy and tolerability.Anne-Marie L Becking, Johannes P M van de Mortel, Oliver Tomkins, Thijs W H Flinsenberg, Nicole Japzon
Leukemia. 2025-03-31 - Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, Mark R Tanner, Qaiser Bashir
British Journal of Haematology. 2025-03-30
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
- Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Sheeba K Thomas, Robert Z Orlowski, Hans C Lee, Clinical Cancer Research
- Phase I Study of an Active Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma with DNA Vaccines Encoding Antigen-Chemokine Fusion: Study ProtocolSattva S Neelapu, D Lynne Smith, Vincent Y Lee, Larry W Kwak, Sheeba K Thomas, BioMed Central
Abstracts/Posters
- Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-HodgkinÍs Lymphoma and C...Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Phase I trial of a novel DNA vaccine in patients (pts) with smoldering Waldenstrom macroglobulinemia (sWM).2019 ASCO Annual Meeting - 6/1/2019
- Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: